New study: Montreal researchers identify three drugs that could reduce mortality in patients with severely ill COVID-19
Researchers at RI-MUHC and the McGill Genome Center examine the differences in ICU patients who recovered or died from COVID-19 and identify candidate drugs to treat serious illnesses. Montreal, June 1, 2022 – Despite the availability of highly effective vaccines, SARS-CoV-2 still causes serious medical complications. The lack of effective drug treatment for hospitalized patients …